Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

Blood Adv · 2026 · PMC13352172 · PMID 42118855

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

In the overall cohort, adverse outcomes were driven primarily by Comp- KRAS , whereas Comp- NRAS showed only a nonsignificant trend toward inferior survival, likely reflecting limited power.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.